Category Archives: Artificial Intelligence
Why Artificial Intelligence is Key to Community-Driven Threat Intelligence – ITPro Today
Date: Thursday, February 17th, 2022Time: 11:00 AM Eastern Standard TimeDuration: 1 hour
Community-driven threat intelligence is all about the collection of network information from a myriad of sources, open and proprietary. The variety and volumes of data mean that there is a lot of analysis to identify potential threats beyond the obvious signatures and known bad actors.
Zero-day threats and stealth attacks can be discovered through community-driven threat intelligence. Powerful artificially intelligent systems are needed to model and learn about the behaviors in the enormous data volumes to avoid event fatigue.
In this webinar, learn:
Brought to you by:
Register Now!If you have already registered,click here to access.
Speakers:
Frank Yue, Principal Solutions Architect and Product EvangelistFrank Yue is a technology evangelist that translates products and technologies into business needs and values. Mr. Yue looks at the evolving technology landscape and how it impacts IT architectures and organizations. He writes blogs, produces white papers, and speaks at conferences and events related to application networking technologies. Mr. Yue has over 25 years of experience building large-scale networks and working with high performance application technologies including deep packet inspection, network security, and application delivery. Mr. Yue works for Snapt and has worked for technology companies in technical and strategic messaging roles. Mr. Yue is a scuba diving instructor and background actor when he is not discussing technology.
Read more:
Why Artificial Intelligence is Key to Community-Driven Threat Intelligence - ITPro Today
193 countries adopt the first global agreement on the Ethics of Artificial Intelligence – UN News
Artificial intelligence is present in everyday life, from booking flights and applying for loans to steering driverless cars. It is also used in specialized fields such as cancer screening or to help create inclusive environments for the disabled.
According to UNESCO, AI is also supporting the decision-making of governments and the private sector, as well as helping combat global problems such as climate change and world hunger.
However, the agency warns that the technology is bringing unprecedented challenges.
We see increased gender and ethnic bias, significant threats to privacy, dignity and agency, dangers of mass surveillance, and increased use of unreliable AI technologies in law enforcement, to name a few. Until now, there were no universal standards to provide an answer to these issues, UNESCO explained in a statement.
Considering this, the adopted text aims to guide the construction of the necessary legal infrastructure to ensure the ethical development of this technology.
The world needs rules for artificial intelligence to benefit humanity. The Recommendation on the ethics of AI is a major answer. It sets the first global normative framework while giving States the responsibility to apply it at their level. UNESCO will support its 193 Member States in its implementation and ask them to report regularly on their progress and practices, said Audrey Azoulay, UNESCO chief.
Unsplash/Maxime Valcarce
The increase in data is key to advances made in artificial intelligence.
The text aims to highlight the advantages of AI, while reducing the risks it also entails. According to the agency, it provides a guide to ensure that digital transformations promote human rights and contribute to the achievement of the Sustainable Development Goals, addressing issues around transparency, accountability and privacy, with action-oriented policy chapters on data governance, education, culture, labour, healthcare and the economy.
One of its main calls is to protect data, going beyond what tech firms and governments are doing to guarantee individuals more protection by ensuring transparency, agency and control over their personal data. The Recommendation also explicitly bans the use of AI systems for social scoring and mass surveillance.
The text also emphasises that AI actors should favour data, energy and resource-efficient methods that will help ensure that AI becomes a more prominent tool in the fight against climate change and in tackling environmental issues.
Decisions impacting millions of people should be fair, transparent and contestable. These new technologies must help us address the major challenges in our world today, such as increased inequalities and the environmental crisis, and not deepening them. said Gabriela Ramos, UNESCOs Assistant Director General for Social and Human Sciences.
You can read the full text here.
Read the original here:
193 countries adopt the first global agreement on the Ethics of Artificial Intelligence - UN News
Artificial intelligence and mobility, who’s at the wheel? – Innovation Origins
Last week, the Dutch Scientific Council for Government Policy (WRR) found that the Netherlands is not well prepared for the consequences of artificial intelligence (AI). In Challenge AI, The New Systems Technology (in Dutch), the council calls for regulation of technology and data, its use, and social implications. And rightly so. Machines will have more computing power than humans in a few decades. If devices with artificial intelligence then start to think and decide for themselves, it is to be hoped that they will observe a number of commandments.
AI is also entering mobility, and the problems the WRR refers to are also at play there. The most imaginative AI appearance in mobility is the autonomous car. It is potentially much safer and more comfortable, but there are tricky liability issues if an accident occurs. Should you as a human always be able to override the system? And what would it take for a self-driving car to interpret the law flexibly when necessary? This is something we, as humans, do every minute in daily traffic, precisely in the service of safety.
One day, when I was driving along with traffic at 120 km/h on the E25 through the Ardennes, my automatic cruise control suddenly lowered the speed limit to 70 km/h because the road workers had forgotten to remove a speed sign. Fortunately, I was able to override that and not adhere to that officially legal speed limit. Despite this example, however, in the future, we should not start allowing extremely smart machines to be flexible with the rules, just like us, without any ethical or moral framework. That could lead to dystopian states where machines, perhaps unintentionally, start endangering humanity.
Want to be inspired 365 days per year? Heres the opportunity. We offer you one "origin of innovation" a day in a compact Telegram message. Seven days a week, delivered around 8 p.m. CET. Straight from our newsroom. Subscribe here, it's free!
But the AI issues in mobility go far beyond the self-driving car. What if Google or TomTom takes over traffic management from the road authority? What if the big tech giants take over the entire planning of public transport once people plan their journeys solely through their services? What if those platforms, after a friendly free initial period, start abusing their achieved monopolies? Who will guarantee availability and safety? Cab services like Uber are more popular than the classic taxi, but who can oblige them, as with regulated cab transport, to also accept guide dogs and wheelchairs, for example, so that a significant part of society is not left aside?
Artificial intelligence will make mobility better, safer, and more comfortable. But these systems need ethical and moral frameworks within which they can achieve this. In the Netherlands, companies, and knowledge institutions have already united in the Dutch AI Coalition. They received 276 million from the growth fund earlier this year to strengthen the Dutch position internationally. Wisely, the first part of that goes to so-called Elsa labs: Ethical, Legal & Societal aspects of AI, in which consortia focus on these aspects. Just as in mobility, AI will help steer other areas as well, but we still want to be able to take the wheel ourselves.
Maarten Steinbuch and Carlo van de Weijer are alternately writingthis weekly column, originally published (in Dutch)in FD. Did you like it? Theres more to enjoy: a book with a selection of these columns has just been published by24U and distributed byLecturis.
See the original post here:
Artificial intelligence and mobility, who's at the wheel? - Innovation Origins
Global AI (Artificial Intelligence) Market Report 2021: Ethical AI Practices and Advisory will be Incorporated in AI Technology Growth Strategy to…
DUBLIN, Nov. 25, 2021 /PRNewswire/ -- The "Future Growth Potential of the Global AI Market" report has been added to ResearchAndMarkets.com's offering.
Artificial intelligence (AI) is transforming organizations, industries, and the technology landscape. The world is moving to the increased adoption of AI-powered smart applications/systems, and this trend will increase exponentially over the next few years. AI technologies are maturing, and the need to leverage their capabilities is becoming a CXO priority.
As businesses make AI part of their core strategy, the transformation of business functions, measures, and controls to ensure ethical best practices will gain importance. The implementation and the governance of ethical AI practices will become a priority and a board-level concern.
The deployment of AI solutions that are ethical (from a regulatory and a legal standpoint), transparent, and without bias will become essential. As governments and industry bodies across the world articulate AI regulations, AI companies must establish their ethical frameworks until roadmaps are clearly defined.
The operationalization of ethical AI principles is challenging for enterprises, given the large volumes of user-centric data that need to be processed, the breadth of use-cases, the regulatory variations in operating markets, and the diverse stakeholder priorities.
This also opens up opportunities for technology vendors and service providers. To effectively partner with enterprises and monetize these opportunities, ICT providers need to assess potential areas impacting AI ethics and evaluate opportunities across the people-process-technology spectrum.
Forward-thinking technology and service companies, including large ICT providers and start-ups, are working with enterprises and industry stakeholders to leverage potential opportunities. Ethical challenges will continue to be discovered and remediated to create sustained growth in potential advisory services.
As enterprises define goals, values, strategic outcomes, and key performance metrics, the time is right for technology companies to strategically partner with enterprises in the detection and the mitigation of ethical AI concerns.
Key Topics Covered:
1. Strategic Imperatives
2. Growth Environment
3. Growth Opportunity Analysis
4. Growth Opportunity Universe
For more information about this report visit https://www.researchandmarkets.com/r/l7isqw
Media Contact:
Research and Markets Laura Wood, Senior Manager [emailprotected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
http://www.researchandmarkets.com
See the original post here:
Global AI (Artificial Intelligence) Market Report 2021: Ethical AI Practices and Advisory will be Incorporated in AI Technology Growth Strategy to...
[Webinar] Balancing Compliance with AI Solutions – How Artificial Intelligence Can Drive the Future of Work by Enabling Fair, Efficient, and Auditable…
December 7th, 2021
2:00 PM - 3:00 PM EDT
*Eligible for HRCI and SHRM recertification credits
With the expansion of Talent Acquisition responsibilities and complex landscape from hiring recovery, talent redeployment, the great resignation, and DE&I initiatives, there has never been a greater need for intelligent, augmentation and automation solutions for recruiters, managers, and sourcers. There is also growing awareness of problematic artificial intelligence solutions being used across the HR space and the perils of efficiency and effectiveness solutions at the cost of fairness and diversity goals. These concerns are compounded with increased inquiries from employees and candidates of the AI solutions used to determine or influence their careers, particularly whats inside the AI and how they are tested for bias. Join this one-hour webinar hosted by HiredScore CEO & Founder Athena Karp as she shares:
Speakers
Athena Karp
CEO & Founder @HiredScore
Athena Karp is the founder and CEO of HiredScore, an artificial intelligence HR technology company that powers the global Fortune 500. HiredScore leverages the power of data science and machine learning to help companies reach diversity and inclusion goals, adapt for the future of work, provide talent mobility and opportunity, and HR efficiencies. HiredScore has won best-in-class industry recognition and honors for delivering business value, accelerating HR transformations, and leading innovation around bias mitigation and ethical AI.
Artificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros – KULR-TV
Lindera one of the leading deep-tech companies in the field of computer vision has successfully closed a Series A financing round. The Berlin-based health-tech company is receiving additional growth capital from new investors as well as from its existing shareholders from the Rheingau Founders circle. With its technology, Lindera is democratising the use of high-precision 3D motion tracking in the healthcare sector. Lindera's scientifically tested and validated solution makes it possible to create motion analyses with a smartphone camera, comparable to the gold standard in measurement accuracy (GAITRite).
Karsten Wulf, Co-founder of buw Holding and Shareholder of family office zwei.7, comments on his investment: "Given the demographic developments and ongoing shortage of skilled care professionals, we see enormous potential in digital health and care applications. This is not only about the sustainable improvement of efficiency but also about increasing the quality of patient care. We are convinced that Lindera, with the cutting-edge digital technology it has developed in-house and its scientific excellence, will play an important role in this area while at the same time keep the focus on people." Commenting on the successful financing round, Diana Heinrichs, Founder and CEO of Lindera, says: "Similar to how Amazon has evolved from a pioneer in online book retail to one of the leading tech companies, backed by zwei.7 we are now developing from an AI pioneer in care into a movement specialist along the entire health supply chain."
With its AI-based mobility analysis, Lindera SturzApp, the Berlin-based company is already successfully in use in more than 350 care facilities and therapy centres throughout Germany. Its customer base includes some of the largest German care facility operators. Lindera is also planning to expand internationally via a pilot project in Paris. In addition, long-term cooperations with customers and health insurance companies, as well as deep roots in the care structures, have created the basis for further growth.
In addition to nursing care, Lindera has been deploying its technology in other medical areas for a long time. The company is using patented, self-learning computer vision technology to address inefficiencies in care structures and to standardise billing-relevant movement assessments at the highest level with the goal of increasing the quality of care measurably. As a result, Lindera aims to use its AI-driven medical devices to make lasting changes in other healthcare areas, such as orthopaedics, geriatrics, neurology, and physical rehabilitation. With "LTech" its own software development kit Lindera also provides its smart 3D algorithm to developers of other healthcare applications, contributing to the development of apps, for example, in the field of physiotherapy.
Within the care sector, Lindera has now received one of the largest investments in the DACH region to date. The team intends to use the additional capital to establish an objective, patient-centred quality standard in care, grow internationally, and advance the development for admission, treatment, and discharge management in hospitals.
Issued by news aktuell/ots on behalf of Lindera GmbH
See the article here:
Artificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros - KULR-TV
At LI hospitals, the artificial intelligence revolution has already begun – Newsday
The words "artificial intelligence" evoke a futuristic world, but at certain Long Island hospitals, the future is here and now.
At some hospitals, nurses track the severity of patients symptoms with help from artificial intelligence, a broad term that encompasses computer programs that can be fed huge volumes of data and trained to analyze new data.
Others use A.I. to predict which patients are at risk of becoming ill again because they dont follow instructions after theyre discharged, or those who are healthy enough to be allowed to sleep through the night instead of being awakened to have their vital signs checked. Still others use the technology to speed the analysis of sleep studies that help diagnose conditions such as sleep apnea.
The ventures vary widely in their origins, scope and funding. One is a new company called Truveta, formed in an unusual alliance between New Hyde Park-based Northwell Health and 19 other health systems across the country. The company, which recently announced $200 million in new private funding, pulls information from millions of the networks patient records anonymized to protect confidentiality and provides real-time analysis to health care providers.
Northwell Healthhas joined forces with 19 other health systems to start acompany called Truveta, which recently announced $200 million in new private funding from its member networks and its CEO, Terry Myerson. Using information from millions of the networks anonymized patient records, the company provides real-time analysis to health-care providers.
NYU Langone Hospital-Long Islandin Mineola has launched an A.I.-powered program that tracks COVID-19 patients vital signs, lab results and other information, recording17 data points every 30 minutes to detect signs of potential deterioration.
Mount Sinai South Nassau in Oceansideuses A.I. to detect patients' risks of falling or becoming severely ill, and to predict how much nursing care they will need.
Stony Brook University'sDepartment of Biomedical Informaticshas received more than $5 million in federal grants to research the potential use of A.I. in diagnosing and treating cancer.
Catholic Health uses A.I.to analyze patients' brain waves, breath patterns, cardiac signals, leg movements and other data points recorded during sleep studies, speeding up the completion of reports that are reviewed by board-certified physicians.
Sources: Northwell Health, NYU Langone Health,Mount Sinai South Nassau,Stony Brook University,Catholic Health
Northwell sees "revolutionary potential" in A.I., Dr. Martin Doerfler, Northwells senior vice president of clinical strategy and development, said in an interview, "and we wanted to be part of it."
On a different scale, another new program got its start on a local nurses laptop during the coronavirus surge last year. After months of research and development, it evolved into an A.I. tool that flags COVID-19 patients at NYU Langone Hospital-Long Island who are at high risk of becoming severely ill in the next 12 hours.
The A.I. program "doesn't take over your decision-making and it never should," said Jeanmarie Moorehead, senior director of operations at the Mineola hospital. "But it is definitely value-added, tremendous value-added to the clinician."
What the A.I. efforts have in common is an ambitious effort to use specialized computer programs to comb through columns of data too vast to be understood by a human being, detect patterns and use that information to guide health care providers in diagnosing and treating patients.
The use of A.I. in health care is on the rise, with global funding in the sector reaching $8.5 billion from January through September nearly double the amount in all of 2019, according to CB Insights, a company that tracks A.I. investments. The United States was the biggest spender, with investments in A.I. in health care totaling $5.45 billion from January through September, the company reported.
Health care technology, including A.I., "is clearly seeing an increased level of investment," especially over the last year and a half, said Peter Micca, a partner and national health tech leader with Deloitte & Touche LLP in Manhattan. "COVID has only accelerated the awareness around the importance of technology in health care."
One hurdle is that, in contrast with industries such as finance and social media, health care data "is completely fragmented," Doerfler said. "We need to know the answers that are hidden inside the fragmented data, and you don't get the answers until you get the data sets large enough that you can find the answers quickly."
Incomplete data sets often lack diversity of race, gender, socioeconomic status and other characteristics, and overrepresent middle-aged white men with health insurance, Doerfler said. By contrast, said Terry Myerson, Truveta's CEO, the data set drawn from its 20 networks represents 16% of all clinical care provided in the United States and reflects "the diversity of our country."
The goal of Truveta, Myerson said, is to "empower our clinicians to be experts" and "help families make the most informed decisions about their care."
Some industry analysts warn of potential pitfalls in the adoption of A.I. At the annual conference of Stony Brook University's Center of Excellence in Wireless and Information Technology this month, Daniel Holewienko, executive director, big data and business intelligence at Henry Schein in Melville, said failing to embrace A.I. would put health care companies "at a competitive disadvantage."
Still, he said, those adopting the new technology can face high costs and difficulties integrating it into their current systems, among other challenges. Protecting privacy, preventing bias and making sure clinicians do not place excessive faith in the machines are among the other concerns, health care providers say.
Dr. Joel Saltz, founding chair of the Department of Biomedical Informatics at Stony Brook University, said the industry has proceeded cautiously in adopting A.I. The advanced technology has become more widely used in the last five years or so, he said.
"These things are incremental, especially in health care, because you've got to make sure they're safe and effective," said Saltz, who is working with colleagues on a project led by the federal Food and Drug Administration, focusing on the use of A.I. in digital pathology. Such tools, he said, are used for "decision support," to aid doctors and nurses rather than replace their work.
Stony Brook's biomedical informatics department is working on three projects funded by more than $5 million in federal grants to research the potential use of A.I. in diagnosing and treating cancer. An A.I. program can examine hundreds of slides and analyze millions of cells, complementing doctors' ability to visually classify tumors, Saltz said. "Think about the difference between a paper map and Google Earth," Saltz said. "It really opens up a whole new way of doing things."
It's possible that some of the research could be put into clinical practice within 10 years, he said.
In some cases, the COVID-19 crisis has sparked innovation by doctors, researchers and nurses as they raced to understand the new virus and find ways to save patients lives. Nurses have been key players in using and, in at least one case, helping to develop the new technology.
At NYU Langone Hospital-Long Island in Mineola, for instance, computers are running a new A.I.-powered program that keeps an eye on COVID-19 patients vital signs, lab results and other information, using patients' electronic medical records to monitor 17 data points every 30 minutes and detect signs of impending danger.
A paper version of the program was born of necessity during the first COVID surge in early 2020. At the time, nurse clinician Cathrine Abbate was seeking a rapid, consistent way to communicate with her fellow nurses and doctors about the severely ill patients suffering from a new and brutal virus.
On video conference calls before and after their shifts, Abbate and other nurses brainstormed about the warning signs that tended to precede a rapid decline in patients condition, such as needing large amounts of oxygen or not being able to eat or move. With that information, she used Microsoft Word to create a blank grid that she printed out at her home in Huntington Station. The grid included seven columns, tracking information about the patients condition. In the hospital, using copies of the grid made it easier for nurses to quickly rank the severity of each symptom and give an overall rating from 1 to 10, with 10 being the worst, she said.
"We needed to be able to fluidly communicate with each other about how the patients were doing," Abbate recalled. "It was just a way to create a language for ourselves."
Nurse manager Sarojini Seemungal helped implement the new system on the 30-bed unit, and alerted her own managers. Moorehead brought it to the attention of researchers at NYU Langone in Manhattan who specialize in analyzing data.
The researchers spent months meeting weekly with nurses and developing an A.I. program that provides information to a rapid response team of critical care nurses at the Long Island hospital who give special attention to the highest-risk patients, said Dr. Yindalon Aphinyanaphongs, director of operational data science and machine learning at NYU Langone Health.
The program acts as a "tireless monitor," taking information about thousands of previous patients including many whose conditions deteriorated and using it to predict whether current patients are likely to decline, he said.
Theres a lot of "hype" about A.I. and its subset machine learning, a term that refers to computers learning from examples, Aphinyanaphongs said.
"A lot of times when people think of artificial intelligence, they think of, you know, WALL-E," he said, in a reference to the 2008 animated movie about a lonely robot. But in fact, "the value in some of these models has to do with, not doing something better than humans, but doing things faster than humans can do," and more consistently, he said.
A tool like the one developed by the nurses and researchers, he said, can take a health care provider who has little experience with COVID, and it "can help elevate their experience and their expertise to the point where they're functioning at the same sort of assessment level as someone who has seen a lot of COVID patients."
The program can be downloaded for free by other hospitals that use the Epic electronic medical records system, Aphinyanaphongs said.
At Mount Sinai South Nassau in Oceanside, computers use A.I. to make sure patients receive precise, personalized care, taking into account the severity of their illnesses and other factors, said Stacey Conklin, chief nursing officer and senior vice president of patient care services. Those at higher risk of falls, for example, get extra help moving around if needed, she said.
A.I. "takes a lot of the subjectivity away from staffing, and allows us to really put the resources where they're needed most," Conklin said. "If I as a manager am trying to figure out where to put all of my resources, it's very helpful for me to be able to look broadly across the unit and see what's going on with all the patients so that I can ensure that the patients are getting the best care."
At the Catholic Health systems six sleep labs, A.I. is used to analyze the sleep studies of patients who spend the night hooked up to machines that record brain waves, breath patterns, cardiac signals, leg movements and other data points to diagnose conditions such as sleep apnea, said Brendan Duffy, director of sleep services at the network.
The data can fill hundreds of pages, and analyzing the information is "a very time-consuming, very meticulous" process that used to take one to two hours for each report, Duffy said.
Once the health system started using the A.I. program about three months ago, he said, that time was reduced to about 20 minutes, he said.
The new system means the sleep labs can get patients on the calendar for follow-up appointments more quickly, so patients spend less time driving while drowsy or suffering compromised immune systems due to sleep deprivation, he said.
But despite their remarkable efficiency, he said, the computers cant have the last word.
A board-certified physician reviews the sleep reports "each and every time, and that's nonnegotiable," he said.
At Northwells Feinstein Institutes for Medical Research in Manhasset, researchers used A.I. to analyze 24 million patient vital sign measurements. The results helped them predict which patients were low-risk enough to sleep through the night with a nurse looking in on them periodically, instead of being awakened to have their vitals checked, according to an article published last year in the journal Nature Partner Journals Digital Medicine.
The health system also is using A.I. to identify certain high-risk patients, said Dr. Jamie Hirsch, director of Northwells data science program.
In presentations about A.I., Hirsch tells his fellow physicians the technology can help identify people such as a fictional patient he has dubbed "Ethel," a sprightly 87-year-old grandmother who is "fiercely independent," but who feels overwhelmed in the hospital, lives alone and might need more assistance than she realizes.
In a busy hospital filled with hundreds of patients, a patient like Ethel might not get the hand-holding she needs, he said.
But when an A.I. program is trained to flag patients who are older, live alone and are coping with a bewildering array of medications and discharge instructions, he said, "now you have a patient experience specialist that's going to come in and say, How are you? Let's sit down, let's talk, you know, how can we make your experience better . How do we get you home, so you can continue living that independent life that you so value?"
He said, "It allows us to focus our energies in the right way, to the right person, at the right time."
Maura McDermott covers health care and other business news on Long Island.
Follow this link:
At LI hospitals, the artificial intelligence revolution has already begun - Newsday
Sunnybrook launches innovative new artificial intelligence research lab with $1-million gift from TD Bank Group – Canada NewsWire
TORONTO, Nov. 25, 2021 /CNW/ - TD Bank Group has donated a $1-million gift to establish the Augmented Precision Medicine Lab at Sunnybrook Health Sciences Centre. The Augmented Precision Medicine Lab will develop cutting-edge artificial intelligence (AI) systems to help improve the clinical care that patients receive in the fields of cardiology, cancer and other chronic diseases. Sunnybrook's rich and complex data stores will be harnessed to develop clinical risk prediction models that will enable physicians to provide personalized care to patients and potentially improve outcomes.
With this investment, Sunnybrook will have the resources it needs to build technological infrastructure, attract more talent, and accelerate a number of innovative projects either planned or underway.
"This generous gift will unite medical experts, computer scientists and industry partners to harness the power of big data and machine learning to drive personalized approaches to medicine," says Kelly Cole, President and CEO, Sunnybrook Foundation. "TD has long been a dedicated supporter of innovation at Sunnybrook and we are delighted to take this next step together."
The Augmented Precision Medicine Lab will work closely with industry partners to develop powerful new diagnostic tools, bring them to communities across Canada, and ultimately improve health outcomes.
"AI in medicine will undoubtedly improve the quality of care that patients receive, and, perhaps more importantly, it will improve health-care equity by dramatically widening access to underserved communities and populations," says Dr. Alexander Bilbily, a physician and computer scientist at Sunnybrook who will serve as the director of the new lab. "And by recognizing the essential role that industry plays in health care, we create a clear path from the lab to the patient where these tools can have a real impact on the patient journey."
The Augmented Precision Medicine Lab's first project aims to leverage Sunnybrook's extensive experience with patients with COVID-19 to create AI tools that can identify which patients are more likely to deteriorate. As a result, doctors will be empowered to closely monitor and improve care for these patients. The tool is being developed for use in smaller community hospitals, which demonstrates how AI can extend the reach of medical knowledge to smaller centres with less experience, thereby improving health-care equity for patients in underserved areas.
"The funding announced today will help Sunnybrook enhance its research and develop AI technologies to advance quality health care for patients who need it most," says Janice Farrell Jones, Senior Vice President, Sustainability and Corporate Citizenship, TD Bank Group. "Through the TD Ready Commitment, the Bank's corporate citizenship platform, we are proud to support this important initiative that will ultimately help patients living with cardiac conditions, cancer and other chronic diseases access equitable and personalized care."
Together, Sunnybrook and TD Bank Group are inventing the future of health care.
About Sunnybrook
Sunnybrook Health Sciences Centre is inventing the future of health care for the 1.3 million patients the hospital cares for each year through the dedication of its more than 10,000 staff and volunteers. An internationally recognized leader in research and education and a full affiliation with the University of Toronto distinguishes Sunnybrook as one of Canada's premier academic health sciences centres. Sunnybrook specializes in caring for high-risk pregnancies, critically ill newborns and adults, offering specialized rehabilitation, and treating and preventing cancer, cardiovascular disease, neurological and psychiatric disorders, orthopaedic and arthritic conditions and traumatic injuries. The hospital also has a unique and national leading program for the care of Canada's war veterans.
SOURCE Sunnybrook Health Sciences Centre
For further information: Media contact: Samantha Sexton, Sunnybrook Health Sciences Centre, 416.480.4040, [emailprotected]
6 positive AI visions for the future of work – World Economic Forum
Current trends in AI are nothing if not remarkable. Day after day, we hear stories about systems and machines taking on tasks that, until very recently, we saw as the exclusive and permanent preserve of humankind: making medical diagnoses, drafting legal documents, designing buildings, and even composing music.
Our concern here, though, is with something even more striking: the prospect of high-level machine intelligence systems that outperform human beings at essentially every task. This is not science fiction. In a recent survey the median estimate among leading computer scientists reported a 50% chance that this technology would arrive within 45 years.
Importantly, that survey also revealed considerable disagreement. Some see high-level machine intelligence arriving much more quickly, others far more slowly, if at all. Such differences of opinion abound in the recent literature on the future of AI, from popular commentary to more expert analysis.
Yet despite these conflicting views, one thing is clear: if we think this kind of outcome might be possible, then it ought to demand our attention. Continued progress in these technologies could have extraordinarily disruptive effects it would exacerbate recent trends in inequality, undermine work as a force for social integration, and weaken a source of purpose and fulfilment for many people.
In April 2020, an ambitious initiative called Positive AI Economic Futures was launched by Stuart Russell and Charles-Edouard Boue, both members of the World Economic Forums Global AI Council (GAIC). In a series of workshops and interviews, over 150 experts from a wide variety of backgrounds gathered virtually to discuss these challenges, as well as possible positive Artificial Intelligence visions and their implications for policymakers.
Those included Madeline Ashby (science fiction author and expert in strategic foresight), Ken Liu (Hugo Award-winning science fiction and fantasy author), and economists Daron Acemoglu (MIT) and Anna Salomons (Utrecht), among many others. What follows is a summary of these conversations, developed in the Forum's report Positive AI Economic Futures.
Participants were divided on this question. One camp thought that, freed from the shackles of traditional work, humans could use their new freedom to engage in exploration, self-improvement, volunteering, or whatever else they find satisfying. Proponents of this view usually supported some form of universal basic income (UBI), while acknowledging that our current system of education hardly prepares people to fashion their own lives, free of any economic constraints.
The second camp in our workshops and interviews believed the opposite: traditional work might still be essential. To them, UBI is an admission of failure it assumes that most people will have nothing of economic value to contribute to society. They can be fed, housed, and entertained mostly by machines but otherwise left to their own devices.
People will be engaged in supplying interpersonal services that can be provided or which we prefer to be provided only by humans. These include therapy, tutoring, life coaching, and community-building. That is, if we can no longer supply routine physical labour and routine mental labour, we can still supply our humanity. For these kinds of jobs to generate real value, we will need to be much better at being human an area where our education system and scientific research base is notoriously weak.
So, whether we think that the end of traditional work would be a good thing or a bad thing, it seems that we need a radical redirection of education and science to equip individuals to live fulfilling lives or to support an economy based largely on high-value-added interpersonal services. We also need to ensure that the economic gains born of AI-enabled automation will be fairly distributed in society.
One of the greatest obstacles to action is that, at present, there is no consensus on what future we should target, perhaps because there is hardly any conversation about what might be desirable. This lack of vision is a problem because, if high-level machine intelligence does arrive, we could quickly find ourselves overwhelmed by unprecedented technological change and implacable economic forces. This would be a vast opportunity squandered.
For this reason, the workshop attendees and interview participants, from science-fiction writers to economists and AI experts, attempted to articulate positive visions of a future where Artificial Intelligence can do most of what we currently call work.
These scenarios represent possible trajectories for humanity. None of them, though, is unambiguously achievable or desirable. And while there are elements of important agreement and consensus among the visions, there are often revealing clashes, too.
The economic benefits of technological progress are widely shared around the world. The global economy is 10 times larger because AI has massively boosted productivity. Humans can do more and achieve more by sharing this prosperity. This vision could be pursued by adopting various interventions, from introducing a global tax regime to improving insurance against unemployment.
Large companies focus on developing AI that benefits humanity, and they do so without holding excessive economic or political power. This could be pursued by changing corporate ownership structures and updating antitrust policies.
Human creativity and hands-on support give people time to find new roles. People adapt to technological change and find work in newly created professions. Policies would focus on improving educational and retraining opportunities, as well as strengthening social safety nets for those who would otherwise be worse off due to automation.
The World Economic Forums Centre for the Fourth Industrial Revolution, in partnership with the UK government, has developed guidelines for more ethical and efficient government procurement of artificial intelligence (AI) technology. Governments across Europe, Latin America and the Middle East are piloting these guidelines to improve their AI procurement processes.
Our guidelines not only serve as a handy reference tool for governments looking to adopt AI technology, but also set baseline standards for effective, responsible public procurement and deployment of AI standards that can be eventually adopted by industries.
We invite organizations that are interested in the future of AI and machine learning to get involved in this initiative. Read more about our impact.
Society decides against excessive automation. Business leaders, computer scientists, and policymakers choose to develop technologies that increase rather than decrease the demand for workers. Incentives to develop human-centric AI would be strengthened and automation taxed where necessary.
New jobs are more fulfilling than those that came before. Machines handle unsafe and boring tasks, while humans move into more productive, fulfilling, and flexible jobs with greater human interaction. Policies to achieve this include strengthening labour unions and increasing worker involvement on corporate boards.
In a world with less need to work and basic needs met by UBI, well-being increasingly comes from meaningful unpaid activities. People can engage in exploration, self-improvement, volunteering or whatever else they find satisfying. Greater social engagement would be supported.
The intention is that this report starts a broader discussion about what sort of future we want and the challenges that will have to be confronted to achieve it. If technological progress continues its relentless advance, the world will look very different for our children and grandchildren. Far more debate, research, and policy engagement are needed on these questions they are now too important for us to ignore.
Written by
Stuart Russell, Professor of Computer Science and Director of the Center for Human-Compatible AI, University of California, Berkeley
Daniel Susskind, Fellow in Economics, Oxford University, and Visiting Professor, Kings College, London
The views expressed in this article are those of the author alone and not the World Economic Forum.
More here:
6 positive AI visions for the future of work - World Economic Forum
Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial…
GENEVA, SWITZERLAND / ACCESSWIRE / November 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), announced today that it has signed a collaboration agreement (the " Collaboration ") with InveniAI LLC (" InveniAI "), a U.S. based company that has pioneered the application of artificial intelligence and machine learning across biopharma and other industries, in order to identify promising drug candidates to treat rare and specialty diseases.
Under the terms of the Collaboration, InveniAI will use its proprietary platform for the identification of potential pharmaceutical product opportunities using its Pharma Big Data Innovation Lab (" Platform "), consisting of (i) its proprietary AlphaMeld(R) platform, a cloud-based Artificial Intelligence (" AI ") platform that utilizes proprietary machine learning and deep learning based neural networks to identify product opportunities in therapeutic areas, (ii) its cross-functional teams at its Integrated Center of Excellence, and (iii) domain expertise, to generate novel pharmaceutical opportunities and the related development pathway for the development of such concepts.
In the Collaboration, it is expected that InveniAI will utilize its Platform to navigate the volume of data for all regulatory agency approved drugs and their associated active ingredients (Active Pharmaceutical Ingredient (" API ")) to identify potential rare and specialty disease indications for development and commercialization by Relief (" Product Concepts "). InveniAI will seek to prioritize top Product Concepts, associated diseases, scientific packages and evidence to support the potential drug development opportunities by Relief. Relief anticipates InveniAI's Platform will complement its wholly owned subsidiary APR Applied Pharma Research SA's existing capabilities in research and development and drug reformulation. Based on product leads developed by InveniAI, Relief hopes to develop proprietary versions of existing drugs, and to protect those drugs with long-lived intellectual property and defensible patent claims.
Story continues
Under the terms of the Collaboration, Relief will pay InveniAI an initial up-front fee, success milestones and commercialization royalties for the full development program. Additional financial details were not disclosed.
"We believe that the addition of InveniAI's AI-powered capabilities will meaningfully complement our existing drug development efforts. AI is becoming an increasingly important tool in identifying and screening new drug projects and Relief intends to fully leverage this promising technology," stated Raghuram (Ram) Selvaraju, Chairman of Relief. "In partnering with InveniAI, we are accessing decades' worth of expertise which has already led to successful drug re-innovation (e.g., vilazodone for treatment of depression and dexmedetomidine for treatment of agitation) and a proven platform that has been the basis of multiple partnerships with established companies. We believe that our work with InveniAI could generate multiple promising additions to our pipeline that may represent capital-efficient, cost-effective and risk-mitigated approaches to product development. In focusing on the optimization of existing approved APIs, we hope to ensure well-established clinical safety and tolerability for the product concepts identified at inception, giving us a running start in pursuing development of novel uses for these drugs. In our view, this approach will enable us to rapidly and efficiently execute innovation that brings relief to patients suffering from severe and debilitating conditions."
ABOUT RELIEF
Relief focuses primarily on clinical-stage programs based on molecules with a history of clinical testing and use in human patients or a strong scientific rationale. Relief's drug candidate, RLF-100(TM) (aviptadil), a synthetic form of Vasoactive Intestinal Peptide (VIP), is in late-stage clinical testing in the U.S. for the treatment of respiratory deficiency due to COVID-19. As part of its pipeline diversification strategy, in March 2021, Relief entered into a Collaboration and License Agreement with Acer Therapeutics for the worldwide development and commercialization of ACER-001. ACER-001 is a taste-masked and immediate release proprietary powder formulation of sodium phenylbutyrate (NaPB) for the treatment of Urea Cycle Disorders and Maple Syrup Urine Disease. In addition, Relief's recently completed acquisitions of APR Applied Pharma Research SA and AdVita Lifescience GmbH bring to Relief a diverse pipeline of marketed and development-stage programs.
RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbol RLFTF. For more information, visit http://www.relieftherapeutics.com . Follow us on LinkedIn.
CONTACT:RELIEF THERAPEUTICS Holding SAJack WeinsteinChief Financial Officer and Treasurercontact@relieftherapeutics.com
FOR MEDIA/INVESTOR INQUIRIES:Rx Communications GroupMichael Miller+1-917-633-6086mmiller@rxir.com
Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding SA. Such statements involve certain known and unknown risks, uncertainties and other factors, including (i) whether InveniAI will bring to RELIEF THERAPEUTICS Holding SA drug candidates that can be successfully developed by RELIEF THERAPEUTICS Holding SA, (ii) whether RELIEF THERAPEUTICS Holding SA will successfully develop and ultimately market any drug candidate identified by InveniAI, and (iii) those risks discussed in RELIEF THERAPEUTICS Holding SA's press releases and filings with the SIX, which could cause the actual results, financial condition, performance or achievements of RELIEF THERAPEUTICS Holding SA to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. RELIEF THERAPEUTICS Holding SA is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
SOURCE: Relief Therapeutics Holdings AG
View source version on accesswire.com: https://www.accesswire.com/674546/Relief-Therapeutics-and-InveniAI-Sign-a-Strategic-Collaboration-Agreement-to-Identify-New-Product-Development-Opportunities-using-Artificial-Intelligence
Continue reading here:
Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial...